« Back
Home /
Gilteritinib

Gilteritinib

Manufacturer	MedChem Express
Category	Oncology Neuroscience Molecular Targets for Neuroscience Inhibitors & Compound Libraries Small Molecules By Organ Colorectal Cancer Bone Cancer
Type	Inhibitors
Specific against	other
Clone	N/A
Amount	5 mg
Item no.	HY-12432-5mg
Targets	FLT3
CASRN	1254053-43-4
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	Gilteritinib (ASP2215) is a potent and ATP-competitive FLT3/AXL inhibitor with IC50s of 0.29 nM/0.73 nM, respectively.
StorageTemperature	4°C (Powder, stored under nitrogen)
Shipping	Room Temperature
Manufacturers Applications	Cancer-Kinase/protease
MolecularWeight	552.71
Clinical_Information	Launched
Manufacturers Research_Area	Cancer
Solubility	DMSO : 2 mg/mL (ultrasonic)\|Ethanol : 100 mg/mL (ultrasonic; adjust pH to 2 with HCl)
Pathway	Protein Tyrosine Kinase/RTK
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-12432-5mg-safety-datasheet.pdf